Key Financial Figures - Standalone (Rs. in lakhs)
Income Statement for Quarter Ended September 30, 2026:
- Revenue from operations: 3650.65
- Other income: 246.20
- Total Income: 3896.85
- Total Expenses: 1473.35
- Profit before tax: 2423.50
- Current tax: 627.36
- Profit for the period: 1796.14
- Basic EPS: ₹20.96
- Diluted EPS: ₹20.96
Income Statement for Half Year Ended September 30, 2026:
- Revenue from operations: 5945.17
- Other income: 776.47
- Total Income: 6721.64
- Total Expenses: 2462.82
- Profit before tax: 4258.82
- Current tax: 1051.47
- Profit for the period: 3207.35
- Basic EPS: ₹37.43
- Diluted EPS: ₹37.43
Comparative Figures (Quarter):
- Q2 FY26 Revenue: 2791.16
- Q2 FY26 Profit: 1494.08
- Q2 FY26 EPS: ₹17.44
Balance Sheet as at September 30, 2026 (Standalone):
- Property, Plant and Equipment: 647.09
- Investments: 19899.67
- Loans: 311.57
- Inventories: 554.15
- Trade receivables: 5687.77
- Cash and cash equivalents: 1392.41
- Bank balances other than cash: 7288.11
- Total Assets: 37375.61
- Equity Share capital: 856.84
- Reserves: 31044.75
- Total Equity and Liabilities: 37375.61
Cash Flow Statement (Standalone) for H1 FY27:
- Cash from operating activities: 1931.84
- Cash used in investing activities: (1750.27)
- Cash from financing activities: (411.09)
- Net increase in cash: 770.48
- Cash at beginning: 7910.04
- Cash at end: 8680.52
Key Financial Figures - Consolidated (Rs. in lakhs)
Income Statement for Quarter Ended September 30, 2026:
- Revenue from operations: 4828.02
- Other income: 470.76
- Total Income: 5298.78
- Total Expenses: 2869.09
- Profit before tax: 2429.69
- Current tax: 627.36
- Profit for the period: 1802.33
- Profit attributable to owners: 1779.58
- Profit attributable to non-controlling interests: 22.75
- Basic EPS: ₹21.03
- Diluted EPS: ₹21.03
Income Statement for Half Year Ended September 30, 2026:
- Revenue from operations: 8177.10
- Other income: 1085.06
- Total Income: 9262.16
- Total Expenses: 5510.52
- Profit before tax: 3751.64
- Current tax: 1051.47
- Profit for the period: 2700.17
- Profit attributable to owners: 2732.77
- Profit attributable to non-controlling interests: (32.60)
- Basic EPS: ₹31.51
- Diluted EPS: ₹31.51
Balance Sheet as at September 30, 2026 (Consolidated):
- Property, Plant and Equipment: 2561.35
- Investments: 16864.14
- Inventories: 1799.36
- Trade receivables: 6424.51
- Cash and cash equivalents: 3399.02
- Bank balances other than cash: 7288.11
- Total Assets: 40221.59
- Equity Share capital: 855.84
- Reserves: 33900.41
- Non-Controlling Interest: 695.16
- Total Equity and Liabilities: 40221.59
Cash Flow Statement (Consolidated) for H1 FY27:
- Cash from operating activities: 1858.93
- Cash used in investing activities: (815.58)
- Cash from financing activities: (1427.43)
- Net increase in cash: 624.82
- Cash at beginning: 10061.91
- Cash at end: 10687.13
Segment-wise Performance (Consolidated)
The company has two reportable business segments:
Quarter Ended September 30, 2026:
- Agrochemicals Revenue: 325.54
- Diagnostic Kits Revenue: 4502.48
- Agrochemicals Segment Result: (6.82)
- Diagnostic Kits Segment Result: 2442.46
Half Year Ended September 30, 2026:
- Agrochemicals Revenue: 458.88
- Diagnostic Kits Revenue: 7708.22
- Agrochemicals Segment Result: (6.78)
- Diagnostic Kits Segment Result: 3774.62
Regulatory and Compliance Information
- The financial results were reviewed by the Audit Committee and approved by the Board of Directors
- The limited review was conducted by statutory auditors M/s Baheti & Co.
- Filed pursuant to SEBI Listing Regulations 30 and 33
- The company's agrochemical business is seasonal and impacted by weather conditions
- Financial figures rounded off to nearest lakh
- Results available at www.kilpest.com and www.bseindia.com
Entities Involved
- Holding Company: 3B BlackBio Dx Limited
- Subsidiaries included in consolidation: TRU PCR Europe Limited, Coris Holding SRL, Belgium